ClinicalTrials.Veeva

Menu

Effect of Chili Pepper Extract on Weight and Fat Loss and Metabolism Increase

A

Ajinomoto

Status and phase

Completed
Phase 2

Conditions

Overweight
Obesity

Treatments

Dietary Supplement: Chronic consumption of matching placebo
Dietary Supplement: Chronic consumption of chili pepper extract

Study type

Interventional

Funder types

Industry

Identifiers

NCT00825838
CH19-001

Details and patient eligibility

About

The purpose of this study is to test the safety and effectiveness of a purified extract of CH-19 Sweet, containing capsinoids.

Enrollment

80 patients

Sex

All

Ages

25 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Is overweight or obese but otherwise generally healthy who interested in losing weight
  • BMI of 25 to 35 kg/m2
  • Waist/hip ratio of 0.9 or more for male and 0.85 for female.

Exclusion criteria

  • Type 1 or 2 diabetes mellitus
  • cardiovascular disease (other than mild, controlled hypertension or dislidemia)
  • On a weight-loss program within six months

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

80 participants in 2 patient groups, including a placebo group

1
Experimental group
Description:
Oral ingestion of 6mg chili pepper extract
Treatment:
Dietary Supplement: Chronic consumption of chili pepper extract
2
Placebo Comparator group
Description:
Oral ingestion of 0 mg chili pepper extract (matching placebo)
Treatment:
Dietary Supplement: Chronic consumption of matching placebo

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems